Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Baughman

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
AIDS (London, England)|November 1, 1994
Analysis of Pneumocystis carinii organism burden, viability and antigens in bronchoalveolar lavage fluid in AIDS patients with pneumocystosis: correlation with disease severityA G Smulian, M J Linke, M T Cushion, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 1, 1996
Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomasP A Bejarano, R P Baughman, P W Biddinger, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 22, 2010
Fatigue in sarcoidosis: American versus Dutch patientsW P E de Kleijn, M D P Elfferich, J De Vries, et al.
The New England Journal of Medicine|May 30, 1996
Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study GroupA Anzueto, R P Baughman, K K Guntupalli, et al.
The Journal of Infectious Diseases|November 17, 1998
Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failureD J Walker, A E Wakefield, M N Dohn, et al.
American Journal of Respiratory and Critical Care Medicine|March 1, 1997
Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndromeT R Martin, G D Rubenfeld, J T Ruzinski, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 15, 2013
Effect of obesity on patient-reported outcomes in sarcoidosisB S Gvozdenovic, V Mihailovic-Vucinic, M Vukovic, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 24, 1999
The Blau syndrome gene is not a major risk factor for sarcoidosisB A Rybicki, M J Maliarik, C H Bock, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|March 7, 2013
Endpoints for clinical trials of sarcoidosisR P Baughman, M Drent, D A Culver, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|July 30, 2011
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task ForceR P Baughman, S Nagai, M Balter, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
AIDS (London, England)|November 1, 1994
Analysis of Pneumocystis carinii organism burden, viability and antigens in bronchoalveolar lavage fluid in AIDS patients with pneumocystosis: correlation with disease severityA G Smulian, M J Linke, M T Cushion, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 1, 1996
Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomasP A Bejarano, R P Baughman, P W Biddinger, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 22, 2010
Fatigue in sarcoidosis: American versus Dutch patientsW P E de Kleijn, M D P Elfferich, J De Vries, et al.
The New England Journal of Medicine|May 30, 1996
Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study GroupA Anzueto, R P Baughman, K K Guntupalli, et al.
The Journal of Infectious Diseases|November 17, 1998
Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failureD J Walker, A E Wakefield, M N Dohn, et al.
American Journal of Respiratory and Critical Care Medicine|March 1, 1997
Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndromeT R Martin, G D Rubenfeld, J T Ruzinski, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 15, 2013
Effect of obesity on patient-reported outcomes in sarcoidosisB S Gvozdenovic, V Mihailovic-Vucinic, M Vukovic, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 24, 1999
The Blau syndrome gene is not a major risk factor for sarcoidosisB A Rybicki, M J Maliarik, C H Bock, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|March 7, 2013
Endpoints for clinical trials of sarcoidosisR P Baughman, M Drent, D A Culver, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|July 30, 2011
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task ForceR P Baughman, S Nagai, M Balter, et al.
Pageof 17